News
Gilead Sciences, Inc. (NASDAQ:GILD) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. The company rose to ...
HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”), a clinical-stage biopharmaceutical company developing next-generation ...
Tamar Braxton has announced a new brand partnership with Gilead Sciences. The music veteran will help educate and raise ...
Health clinics that serve more than 1.1 million patients up and down the San Joaquin Valley are bracing for the prospect of budget cuts and other fallout in the wake of the passage of President Donald ...
11h
Zacks Investment Research on MSNKymera Surges 70% in 3 Months: Buy, Sell or Hold the Stock?Shares of Kymera KYMR have surged 70.7% in the past three months compared with the industry’s gain of 9.7%. The stock has ...
A remarkable journey through a male-dominated industry was shared by global fleet director Anne-Marie Dunbar at the first ...
Explore more
18h
AllAfrica on MSN10 Things to Know About Effectiveness of New HIV Injectable DrugGlobally, an estimated 4,000 adolescent girls and young women become infected with HIV each week, with sub-Saharan Africa accounting for more than 60% of these new infections, according to the World ...
South Africa will buy lenacapavir using Global Fund money. Studies show it can stop infections entirely in young women. But ...
Several of the events took place at ‘upscale restaurants’ in San Francisco, at costs of up to $163 per person, according to ...
A major HIV drug maker will return $202 million nationwide after a multi-year investigation and settlement. Pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results